Mirogabalin for the treatment of diabetic peripheral neuropathic pain: A randomized, double-blind, placebo-controlled phase III study in Asian patients
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Mirogabalin for the treatment of diabetic peripheral neuropathic pain: A randomized, double-blind, placebo-controlled phase III study in Asian patients
Authors
Keywords
-
Journal
Journal of Diabetes Investigation
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2019-01-24
DOI
10.1111/jdi.13013
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Binding Characteristics and Analgesic Effects of Mirogabalin, a Novel Ligand for theα2δSubunit of Voltage-Gated Calcium Channels
- (2018) Yuki Domon et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Identification, prevalence, and treatment of painful diabetic neuropathy in patients from a rural area in South Carolina
- (2017) Jimmy Pruitt III et al. Journal of Pain Research
- Healthcare utilization and costs in diabetes relative to the clinical spectrum of painful diabetic peripheral neuropathy
- (2015) Alesia Sadosky et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis
- (2015) Nanna B Finnerup et al. LANCET NEUROLOGY
- Suboptimal Treatment of Diabetic Peripheral Neuropathic Pain in the United States
- (2015) Mei Yang et al. PAIN MEDICINE
- Efficacy and Safety of Mirogabalin (DS-5565) for the Treatment of Diabetic Peripheral Neuropathic Pain: A Randomized, Double-Blind, Placebo- and Active Comparator–Controlled, Adaptive Proof-of-Concept Phase 2 Study
- (2014) Aaron Vinik et al. DIABETES CARE
- Burden of Illness Associated with Peripheral and Central Neuropathic Pain among Adults Seeking Treatment in the United States: A Patient-Centered Evaluation
- (2014) Caroline Schaefer et al. PAIN MEDICINE
- Burden of illness associated with painful diabetic peripheral neuropathy among adults seeking treatment in the US: results from a retrospective chart review and cross-sectional survey
- (2013) Alesia Sadosky et al. Diabetes Metabolic Syndrome and Obesity-Targets and Therapy
- Randomized, Placebo-Controlled Comparison of Amitriptyline, Duloxetine, and Pregabalin in Patients With Chronic Diabetic Peripheral Neuropathic Pain: Impact on pain, polysomnographic sleep, daytime functioning, and quality of life
- (2012) J. Boyle et al. DIABETES CARE
- Pregabalin Treatment for Peripheral Neuropathic Pain
- (2012) Setsuro Ogawa et al. DRUG SAFETY
- Considerations for improving assay sensitivity in chronic pain clinical trials: IMMPACT recommendations
- (2012) Robert H. Dworkin et al. PAIN
- Prevalence and Characteristics of Painful Diabetic Neuropathy in a Large Community-Based Diabetic Population in the U.K.
- (2011) C. A. Abbott et al. DIABETES CARE
- Efficacy and safety evaluation of pregabalin treatment over 52 weeks in patients with diabetic neuropathic pain extended after a double-blind placebo-controlled trial
- (2011) Jo Satoh et al. Journal of Diabetes Investigation
- A Longitudinal Assessment of Painful Diabetic Peripheral Neuropathy on Health Status, Productivity, and Health Care Utilization and Cost
- (2010) Marco daCosta DiBonaventura et al. PAIN MEDICINE
- Translating the A1C Assay Into Estimated Average Glucose Values
- (2008) D. M. Nathan et al. DIABETES CARE
- A graphical approach to sequentially rejective multiple test procedures
- (2008) Frank Bretz et al. STATISTICS IN MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started